| 000 | 01811 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514020633.0 | ||
| 264 | 0 | _c20020104 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(20011101)92:9<2419::aid-cncr1591>3.0.co;2-k _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBanfi, A | |
| 245 | 0 | 0 |
_aHigh-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. _h[electronic resource] |
| 260 |
_bCancer _cNov 2001 |
||
| 300 |
_a2419-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmenorrhea _xchemically induced |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aBone Density |
| 650 | 0 | 4 |
_aBone Diseases, Metabolic _xchemically induced |
| 650 | 0 | 4 |
_aBone Marrow Cells _xdrug effects |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHematopoietic Stem Cells |
| 650 | 0 | 4 | _aHomeostasis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xadverse effects |
| 700 | 1 | _aPodestà , M | |
| 700 | 1 | _aFazzuoli, L | |
| 700 | 1 | _aSertoli, M R | |
| 700 | 1 | _aVenturini, M | |
| 700 | 1 | _aSantini, G | |
| 700 | 1 | _aCancedda, R | |
| 700 | 1 | _aQuarto, R | |
| 773 | 0 |
_tCancer _gvol. 92 _gno. 9 _gp. 2419-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(20011101)92:9<2419::aid-cncr1591>3.0.co;2-k _zAvailable from publisher's website |
| 999 |
_c11658307 _d11658307 |
||